| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
Cell Growth & Differentiation, Vol 9, Issue 12 961-967, Copyright © 1998 by American Association of Cancer Research
ARTICLES |
S Bao, X Shen, K Shen, Y Liu and XF Wang
Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.
Cell cycle checkpoint proteins play critical roles in maintaining genomic stability and integrity to prevent the development of cancer and hereditary diseases. Here we report the isolation of a novel mouse gene encoding the protein MmRad24 [MmRad24 is the mouse homologue of HRad17, which was described recently by A. E. Parker et al. (J. Biol. Chem., 273: 18340-18346, 1998)], which shares significant sequence and structural homology with the budding yeast Rad24 and its fission yeast counterpart Rad17, both of which are required for DNA damage checkpoints. Confocal microscopy revealed that the green fluorescent protein-tagged MmRad24 protein is localized to the nucleus in living cells. Fluorescence-activated cell-sorting analysis showed that overexpression of the wild-type MmRad24 in diploid fibroblast WI-38 cells caused a significant G2 arrest of the cell cycle, whereas overexpression of a mutant MmRad24 (mutated on the nucleotide-binding site) that likely functions as a dominant-negative protein resulted in a defect in cell cycle arrest after DNA damage treatment as measured by bromodeoxyuridine pulse-chase labeling experiments. Taken together, these results suggest that the mammalian Rad24 protein may function as a critical gatekeeper in DNA damage checkpoint control.
This article has been cited by other articles:
![]() |
H. Chen, S. Shi, L. Acosta, W. Li, J. Lu, S. Bao, Z. Chen, Z. Yang, M. D. Schneider, K. R. Chien, et al. BMP10 is essential for maintaining cardiac growth during murine cardiogenesis Development, May 1, 2004; 131(9): 2219 - 2231. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, L. Wang, M. D. Callister, J. B. Putnam, L. Mao, and L. Li Human Rad17 Is Phosphorylated upon DNA Damage and also Overexpressed in Primary Non-Small Cell Lung Cancer Tissues Cancer Res., October 1, 2001; 61(20): 7417 - 7421. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. B. Schultz, N. H. Chehab, A. Malikzay, and T. D. Halazonetis P53 Binding Protein 1 (53bp1) Is an Early Participant in the Cellular Response to DNA Double-Strand Breaks J. Cell Biol., December 25, 2000; 151(7): 1381 - 1390. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Griffiths, M Uchiyama, P Nurse, and T. Wang A novel mutant allele of the chromatin-bound fission yeast checkpoint protein Rad17 separates the DNA structure checkpoints J. Cell Sci., January 3, 2000; 113(6): 1075 - 1088. [Abstract] [PDF] |
||||
![]() |
L.B. SCHULTZ, N.H. CHEHAB, A. MALIKZAY, R.A. DITULLIO, E.S. STAVRIDI, and T.D. HALAZONETIS The DNA Damage Checkpoint and Human Cancer Cold Spring Harb Symp Quant Biol, January 1, 2000; 65(0): 489 - 498. [Abstract] [PDF] |
||||
![]() |
S.-T. Kim, D.-S. Lim, C. E. Canman, and M. B. Kastan Substrate Specificities and Identification of Putative Substrates of ATM Kinase Family Members J. Biol. Chem., December 31, 1999; 274(53): 37538 - 37543. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rauen, M. A. Burtelow, V. M. Dufault, and L. M. Karnitz The Human Checkpoint Protein hRad17 Interacts with the PCNA-like Proteins hRad1, hHus1, and hRad9 J. Biol. Chem., September 15, 2000; 275(38): 29767 - 29771. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |